Skip to content
OpenCapital
Get started

OS Therapies OSTX Number of reportable segments

Number of reportable segments at other companies

CTO
Citius Oncology, Inc.CTOR
100%—

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M—
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K—
Free cash flow-$3.7M—

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M—

Returns & leverage

See full
Return on equity470%—
Debt / equity-1.8×—
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:NumberOfReportableSegments.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's number of reportable segments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's number of reportable segments?
OS Therapies (OSTX) reported number of reportable segments of 1 in Q1 2026.
How has OS Therapies's number of reportable segments changed year-over-year?
OS Therapies's number of reportable segments increased by 300.0% year-over-year, from 0.3 to 1.
What does number of reportable segments mean?
The number of business segments that meet the quantitative thresholds for separate disclosure under accounting standards. This metric helps investors understand the transparency and granularity of the company's financial reporting across its various business lines.